KYNAGYLE Trademark

Trademark Overview

On Friday, June 26, 2015, a trademark application was filed for KYNAGYLE with the United States Patent and Trademark Office. The USPTO has given the KYNAGYLE trademark a serial number of 86675916. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 14, 2020. This trademark is owned by Cynapsus Therapeutics Inc.. The KYNAGYLE trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Sublingual thin filmstrip of apomorphine to treat Parkinson's Disease off hypomobility episodes; Pharmaceuticalpreparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; Pharmaceutical preparations for the treatment of Parkinson's Disease; Pharmaceuticals, namely, drug delivery agents in the form of thin filmstrips to sublingually provide controlled release of the active ingredients for a wide variety of pharmaceutical preparations; Therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease; Therapeutics, namely, drug delivery agents in the form of thin filmstrips to sublingually provide controlled release of the active ingredients for a wide variety of therapeutic preparations

Providing medical information regarding Parkinson's Disease and Parkinson's Disease off hypomobility episodes
kynagyle

General Information

Serial Number86675916
Word MarkKYNAGYLE
Filing DateFriday, June 26, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 14, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2017

Trademark Statements

Goods and ServicesSublingual thin filmstrip of apomorphine to treat Parkinson's Disease off hypomobility episodes; Pharmaceuticalpreparations for the treatment of Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; therapeutic pharmaceutical preparations to manage Parkinson's Disease off hypomobility episodes, delivered orally via a sublingual thin filmstrip; Pharmaceutical preparations for the treatment of Parkinson's Disease; Pharmaceuticals, namely, drug delivery agents in the form of thin filmstrips to sublingually provide controlled release of the active ingredients for a wide variety of pharmaceutical preparations; Therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease; Therapeutics, namely, drug delivery agents in the form of thin filmstrips to sublingually provide controlled release of the active ingredients for a wide variety of therapeutic preparations
Goods and ServicesProviding medical information regarding Parkinson's Disease and Parkinson's Disease off hypomobility episodes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 4, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 14, 2015
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSUNOVION PHARMACEUTICALS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMARLBOROUGH, MA 01752
Party NameSUNOVION PHARMACEUTICALS INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressMARLBOROUGH, MA 01752
Party NameCynapsus Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M6J1C9
CA

Trademark Events

Event DateEvent Description
Monday, September 14, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 14, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, February 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 13, 2020EXTENSION 5 GRANTED
Friday, February 7, 2020EXTENSION 5 FILED
Thursday, February 13, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 7, 2020TEAS EXTENSION RECEIVED
Friday, August 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 7, 2019EXTENSION 4 GRANTED
Wednesday, August 7, 2019EXTENSION 4 FILED
Wednesday, August 7, 2019TEAS EXTENSION RECEIVED
Friday, February 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 6, 2019EXTENSION 3 GRANTED
Wednesday, February 6, 2019EXTENSION 3 FILED
Wednesday, February 6, 2019TEAS EXTENSION RECEIVED
Friday, August 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 8, 2018EXTENSION 2 GRANTED
Wednesday, August 8, 2018EXTENSION 2 FILED
Wednesday, August 8, 2018TEAS EXTENSION RECEIVED
Friday, February 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 7, 2018EXTENSION 1 GRANTED
Wednesday, February 7, 2018EXTENSION 1 FILED
Wednesday, February 7, 2018TEAS EXTENSION RECEIVED
Wednesday, February 7, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 8, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 13, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 24, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 8, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, April 27, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 6, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 31, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, February 17, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 17, 2017LETTER OF SUSPENSION E-MAILED
Friday, February 17, 2017SUSPENSION LETTER WRITTEN
Thursday, February 2, 2017PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, January 30, 2017ASSIGNED TO EXAMINER
Wednesday, January 25, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 11, 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, December 16, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 16, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 7, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, August 4, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 4, 2016INQUIRY TO SUSPENSION E-MAILED
Thursday, August 4, 2016SUSPENSION INQUIRY WRITTEN
Thursday, July 14, 2016LIE CHECKED SUSP - TO ATTY FOR ACTION
Tuesday, January 5, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 5, 2016LETTER OF SUSPENSION E-MAILED
Tuesday, January 5, 2016SUSPENSION LETTER WRITTEN
Monday, December 14, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 14, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 7, 2015ASSIGNED TO LIE
Wednesday, November 18, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 25, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 25, 2015NON-FINAL ACTION E-MAILED
Friday, September 25, 2015NON-FINAL ACTION WRITTEN
Friday, September 18, 2015ASSIGNED TO EXAMINER
Saturday, July 4, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

kynagyle disease parkinson preparations thin episodes hypomobility pharmaceutical sublingual therapeutic treatment